Securities code: 002252 securities abbreviation: Shanghai Raas Blood Products Co.Ltd(002252) Announcement No.: 2022-003 shareholder Kerui Tiancheng Investment Holding Co., Ltd. and persons acting in concert
Announcement on passive reduction of Shanghai Raas Blood Products Co.Ltd(002252) shares
The shareholder Kerui Tiancheng Investment Holding Co., Ltd. guarantees that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The Shanghai Raas Blood Products Co.Ltd(002252) (” Shanghai Raas Blood Products Co.Ltd(002252) “) shares pledged by Kerui Tiancheng Investment Holding Co., Ltd. (“Kerui Tiancheng”) to Cinda Securities Co., Ltd. (“Cinda securities”) were enforced by the court due to overdue repayment. Cinda securities sold a total of 37 Shanghai Raas Blood Products Co.Ltd(002252) shares through centralized bidding from December 20, 2021 to January 10, 2022. Therefore, Kerui Tiancheng passively reduced 37 Shanghai Raas Blood Products Co.Ltd(002252) shares (accounting for 0.0000005% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) ).
The Shanghai Raas Blood Products Co.Ltd(002252) shares pledged by Kerui Tiancheng to Jiangxi Ruijing Financial Asset Management Co., Ltd. (“Jiangxi Ruijing”) as a guarantee for a third party were enforced by the court due to the overdue repayment of the guaranteed party. Jiangxi Ruijing sold a total of 72000 Shanghai Raas Blood Products Co.Ltd(002252) shares through centralized bidding from December 20, 2021 to January 10, 2022, Therefore, Kerry Tiancheng passively reduced 72000 shares of Shanghai Raas Blood Products Co.Ltd(002252) (accounting for 0.001% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) ). On September 9, 2021, Kerry Tiancheng disclosed the pre disclosure announcement on the passive reduction of shares of the company by the shareholder Kerry Tiancheng (Announcement No.: 2021-048), and the court served the notice of assistance in execution on First Capital Securities Co.Ltd(002797) (” First Capital Securities Co.Ltd(002797) securities”), It is required to report and sell 38500000 Shanghai Raas Blood Products Co.Ltd(002252) shares pledged by Kerui Tiancheng to First Capital Securities Co.Ltd(002797) securities [representing ” First Capital Securities Co.Ltd(002797) securities stock pledge No. 136 directional asset management plan” and ” First Capital Securities Co.Ltd(002797) securities stock pledge No. 152 directional asset management plan”] at the market price through centralized bidding, and transfer the proceeds from the sale directly to the court account. First Capital Securities Co.Ltd(002797) securities sold a total of 861653 Shanghai Raas Blood Products Co.Ltd(002252) shares through centralized bidding from December 20, 2021 to January 10, 2022. Therefore, Kerui Tiancheng passively reduced 861653 Shanghai Raas Blood Products Co.Ltd(002252) shares (accounting for 0.01% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) ).
21609044 Shanghai Raas Blood Products Co.Ltd(002252) shares pledged to Jinyuan Securities Co., Ltd. (“Jinyuan securities”) by Ningbo Kerui Jinding investment partnership (limited partnership) (“Kerui Jinding”), the concerted actor of Kerui Tiancheng, were enforced by the court due to overdue repayment. The above 21609044 Shanghai Raas Blood Products Co.Ltd(002252) shares have completed the judicial transfer procedures in China Securities Depository and Clearing Co., Ltd. on December 31, 2021. Kerui Jinding therefore passively reduced its Shanghai Raas Blood Products Co.Ltd(002252) shares
21609044 shares (accounting for 0.32% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) ).
In accordance with the securities law and the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of Listed Companies in Shenzhen Stock Exchange, the above-mentioned passive reduction is hereby announced as follows:
1、 Passive share reduction
1. Basic information
Information disclosure obligor: Kerui Tiancheng Investment Holding Co., Ltd
Address: floor 1, building 28, No. 6055, Jinhai highway, Fengxian District, Shanghai
Changes in equity from December 20, 2021 to January 10, 2022
Stock abbreviation Shanghai Raas Blood Products Co.Ltd(002252) stock code 002252
Change type (increase □ decrease √ concerted action person yes √ no □
(multiple choice)
Whether it is the largest shareholder or actual controller yes □ no √
2. Changes in equity
Type of shares (A shares, B shares, etc.) number of shares reduced (10000 shares) reduction proportion (%)
A shares 0.0037 0.000000 5%
A shares 7.20 0.001%
A shares 86.1653 0.01%
A shares 2160.9044 0.32%
Total 2250.34%
Centralized trading through stock exchange □
The method of equity change (multiple choices) is block trading through the stock exchange □
Others √ (please specify) execution of court decisions, etc
Self owned funds □ bank loans □
The capital source of this share increase (borrowing from other financial institutions □ shareholder investment □
(optional) others √ not applicable
Not involving the source of funds □
3. Shares of listed companies owned by investors and persons acting in concert before and after the change
Shares held before this change shares held after this change
Name of shareholders and nature of shares (December 17, 2021) (January 10, 2022)
Proportion of said shares (10000 shares) to total share capital
Keruitian holds 71023.2879 shares 10.54% and 70929.9189 shares 10.52%
Including: shares with unlimited sales conditions 71023.2879 10.54% 70929.9189 10.52%
Shares with limited sales conditions 0
Total shares held 4440.9048 0.66% 2280.0004 0.34%
Kerui gold, including: 4440.9048 0.66% 2280.0004 0.34% Ding shares with unlimited sales conditions
Shares with limited sales conditions 0
Keruitian holds 75465.0561 shares, 11.20% 73210.7827 shares and 10.86% chengheyi shares in total
Action to be taken, including: shares with unlimited sales conditions 75465.0561 11.20% 73210.7827 10.86%
Ren Kerui
Jinding, shares with limited sales conditions
Corey set 0
Mission 4 Performance of commitments, plans, etc
Whether this change is performed yes □ no √
A promise, intention, plan
1、 The reduction of Kerui Tiancheng and the persons acting in concert is due to the creditor’s application to the court for enforcement. Whether there is any passive reduction caused by violation of the securities law in this change, Kerui Tiancheng and the persons acting in concert have not been informed of the above-mentioned passive securities law in advance The acquisition management reduction plan of listed companies, the above-mentioned passive reduction has not been pre disclosed, and the above-mentioned passive reduction has not generated any income measures and other laws, administrative regulations and benefits; Departmental rules, normative documents and the company 2. Kerui Tiancheng and the persons acting in concert have been actively communicating and coordinating with the creditors, and take relevant measures such as debt extension, fund-raising, margin increase or collateral to prevent the risk of closing positions according to the requirements of the business rules required by the creditors; At the same time, it actively won the support of local government departments, and established a debt Committee in the third quarter of 2020 to seek strategic investors to jointly resolve the debt crisis.
5. The shares with restricted voting rights shall be in accordance with Article 63 of the securities law
Yes □ no √
Voting shares 6 Further explanation on the increase of shares held by more than 30% shareholders (not applicable) 7 Documents for future reference 1. Details of shareholding changes of China Securities Depository and Clearing Co., Ltd. √ 2. Relevant written commitment documents □ 3. Written opinions of lawyers □ 4. Other documents required by Shenzhen Stock Exchange √
2、 Other relevant instructions
1. According to several provisions on the reduction of shares held by shareholders and directors, supervisors and senior managers of listed companies (CSRC [2017] No. 9) and the detailed rules for the implementation of the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies of Shenzhen Stock Exchange, Rui Tiancheng and Kerui Jinding, the person acting in concert The total number of shares reduced by Kerui Group Co., Ltd. (“Kerui group”) through centralized bidding trading shall not exceed 1% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) , and the total number of shares reduced through block trading shall not exceed 2% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) . The above passive reduction of shares does not violate the above provisions.
2. Since Shanghai Raas Blood Products Co.Ltd(002252) first issued the pre disclosure announcement on the possible passive reduction of Shanghai Raas Blood Products Co.Ltd(002252) shares by Kerui Tiancheng and persons acting in concert, as of January 10, 2022, Kerui Tiancheng and persons acting in concert have passively reduced 1100479537 shares of Shanghai Raas Blood Products Co.Ltd(002252) shares (accounting for 16.33% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) ). In addition, Kerui Tiancheng and the persons acting in concert did not reduce their holdings of Shanghai Raas Blood Products Co.Ltd(002252) shares.
3. As of January 10, 2022, Kerui Tiancheng held 709299189 Shanghai Raas Blood Products Co.Ltd(002252) shares, accounting for 10.52% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) , pledged 690764247 Shanghai Raas Blood Products Co.Ltd(002252) shares, accounting for 10.25% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) , and frozen 708764289 Shanghai Raas Blood Products Co.Ltd(002252) shares, accounting for 10.51% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) .
4. As of January 10, 2022, Kerui Tiancheng and the persons acting in concert held 732107827 Shanghai Raas Blood Products Co.Ltd(002252) shares, accounting for 10.86% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) , pledged 713564247 Shanghai Raas Blood Products Co.Ltd(002252) shares, accounting for 10.59% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) , and frozen 731572927 Shanghai Raas Blood Products Co.Ltd(002252) shares, accounting for 10.85% of the total share capital of Shanghai Raas Blood Products Co.Ltd(002252) .
5. This reduction is a passive reduction by Kerui Tiancheng and the persons acting in concert. Kerui Tiancheng and the persons acting in concert have been actively communicating and coordinating with the creditors, and take relevant measures such as debt extension, fund-raising, margin call or collateral to prevent the risk of closing positions according to the requirements of the creditors; At the same time, it actively won the support of local government departments, and established a debt Committee in the third quarter of 2020 to seek strategic investors to jointly resolve the debt crisis. 6. At present, Shanghai Raas Blood Products Co.Ltd(002252) is in the state of no controlling shareholder and no actual controller. This passive reduction has no impact on Shanghai Raas Blood Products Co.Ltd(002252) governance structure and sustainable operation.
Information disclosure obligor: Kerui Tiancheng Investment Holding Co., Ltd. January 12, 2002
